Kurt Armbrust. PhD

Entrepreneur in Residence

Kurt Armbrust is an Entrepreneur in Residence (EIR) at Raven, focused on small molecule drug development, specializing in induced proximity drug discovery: PROTACs, molecular glues, and emerging modalities. He was previously a medicinal chemist at Relay Therapeutics, where he championed targeted protein degradation and delivered two development candidates. Prior to that, he spent four years in small molecule drug discovery at Celgene/​Bristol Myers Squibb. He holds a PhD in organic chemistry from MIT and a BS from Brown University.